Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
HTG Molecular Diagnostics
AddedFeb 19, 2024
UpdatedJun 18, 2026
HTG Molecular Diagnostics

HTG Molecular Diagnostics

Public

HTG Molecular Diagnostics, Inc. develops and markets technology for complex molecular profiling and biomarker development.

HQ
Tucson, AZ, US
Founded
1997
Overview
Compare
Fundraising
Employees
Website

HTG Molecular Diagnostics, Inc., founded in Tucson, United States, is dedicated to advancing the field of molecular profiling and biomarker development. The company's core mission is to facilitate the routine use of complex molecular profiling through its innovative technology platform. HTG offers a comprehensive suite of products including instrumentation, consumables, and software analytics designed for applications such as tumor profiling, molecular diagnostic testing, and biomarker development. Their market focus spans across research institutions, clinical laboratories, and pharmaceutical companies.

Notable affiliated individuals and investors include key figures in the biotechnology and healthcare sectors, although specific names are not provided. HTG Molecular Diagnostics has achieved significant milestones in the development and commercialization of their HTG EdgeSeq technology, which has been widely adopted for its efficiency and accuracy in gene expression profiling. The company's impact is evident in its contributions to personalized medicine and precision diagnostics, enhancing the ability to understand and treat complex diseases at a molecular level.

HTG Molecular Diagnostics - Quick Facts

When was HTG Molecular Diagnostics founded?

HTG Molecular Diagnostics was founded in 1997.

Where is HTG Molecular Diagnostics' headquarters located?

HTG Molecular Diagnostics' headquarters is located in Tucson, AZ, US.

When was HTG Molecular Diagnostics' last funding round?

HTG Molecular Diagnostics' most recent funding round was for $10M (USD) in December 2022.

How much has HTG Molecular Diagnostics raised to-date?

As of Dec 21, 2022, HTG Molecular Diagnostics has raised a total of $106.5M (USD).

How many employees does HTG Molecular Diagnostics have?

HTG Molecular Diagnostics has 107 employees as of Feb 5, 2024.

HTG Molecular Diagnostics - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Biomarker Development
  • Molecular Profiling
Tags
  • Biotech
  • Data
  • Healthcare
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334516Analytical Laboratory Instrument Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3826Laboratory Analytical Instruments
ISIC
  • 2651Manufacture of measuring, testing, navigating and control equipment
Show 22 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research